Apolipoprotein A I (APOA1) Mouse Monoclonal Antibody [Clone ID: 5F4F5]

CAT#: AM06220SU-N

Apolipoprotein A I (APOA1) mouse monoclonal antibody, clone 5F4F5, Ascites

Product Images

Western blot analysis using APOA1 antibody Cat.-No AM06220SU-N against HEK293T cells transfected with the pCMV6-ENTRY control (Lane 1) and pCMV6-ENTRY APOA1 cDNA (Lane 2).

• 

  Western blot analysis using APOA1 antibody Cat.-No AM06220SU-Nagainst HepG2 cell lysate (Lane 1) and human serum (Lane 2).

Specifications

Product Data

• Clone Name: 5F4F5
• Applications: ELISA, WB
• Recommended Dilution: ELISA: 1/10000.
  Western Blot: 1/500 - 1/2000.
• Reactivities: Human
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Immunogen: Purified recombinant fragment of Human APOA1 expressed in E. Coli.
• Specificity: Recognizes Apolipoprotein A-I (APOA1)
• Formulation: State: Ascites
  State: Ascitic fluid containing 0.03% Sodium Azide.
• Conjugation: Unconjugated
• Storage: Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
  Avoid repeated freezing and thawing.
• Stability: Shelf life: one year from despatch.
• Gene Name: apolipoprotein A1
• Database Link:
  Entrez Gene 335 Human
  UniProt ID P02647
• Background: Apolipoprotein A-I, it is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.
• Synonyms: APOA1, ApoA-I, Apo-AI, ApoAI